ClearSight Therapeutics


ClearSight Therapeutics is a Dallas-based biotech company founded in 2023 by eye care industry veterans. The company is dedicated to developing innovative, over-the-counter (OTC) solutions for common eye conditions such as dry eye and pink eye (acute infectious conjunctivitis). With a mission to disrupt the traditional OTC eye care industry, ClearSight leverages a proprietary platform that combines the dual-action potency of leading artificial tears and a powerful antimicrobial biopolymer. Their vision is to provide safe, effective, and accessible treatments that put patients first, while upholding ethical and responsible research and development practices.

ClearSight Therapeutics

ClearSight Therapeutics


What We Do

A next-generation OTC eye drop built on ClearSight's proprietary platform, combining artificial tears with a powerful antimicrobial biopolymer to soothe dry, irritated eyes and combat infection, rapidly reducing redness, swelling, and discomfort.

ClearSight Therapeutics develops over-the-counter treatments for common eye conditions, focusing on dry eye and pink eye, using a proprietary dual-action platform.


Application Area


Key People

Chief Executive Officer

Chief Scientific Officer

Lead Clinical Consultant

COO (Fractional)

CFO (Fractional)

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.